Efficient shRNA-Mediated Inhibition of Gene Expression in Zebrafish

1 Whitehead Institute for Biomedical Research , Cambridge Massachusetts.
Zebrafish (Impact Factor: 1.77). 07/2012; 9(3):97-107. DOI: 10.1089/zeb.2012.0770
Source: PubMed

ABSTRACT Abstract Despite the broad repertoire of loss of function (LOF) tools available for use in the zebrafish, there remains a need for a simple and rapid method that can inhibit expression of genes at later stages. RNAi would fulfill that role, and a previous report (Dong et al. 2009) provided encouraging data. The goal of this study was to further address the ability of expressed shRNAs to inhibit gene expression. This included quantifying RNA knockdown, testing specificity of shRNA effects, and determining whether tissue-specific LOF could be achieved. Using an F0 transgenic approach, this report demonstrates that for two genes, wnt5b and zDisc1, each with described mutant and morphant phenotypes, shRNAs efficiently decrease endogenous RNA levels. Phenotypes elicited by shRNA resemble those of mutants and morphants, and are reversed by expression of cognate RNA, further demonstrating specificity. Tissue-specific expression of zDisc1 shRNAs in F0 transgenics demonstrates that conditional LOF can be readily obtained. These results suggest that shRNA expression presents a viable approach for rapid inhibition of zebrafish gene expression.

Download full-text


Available from: Jennifer H Gutzman, Jun 02, 2015
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The Japanese medaka, Oryzias latipes, is a vertebrate teleost model with a long history of genetic research. A number of unique features and established resources distinguish medaka from other vertebrate model systems. A large number of laboratory strains from different locations are available. Due to a high tolerance to inbreeding, many highly inbred strains have been established, thus providing a rich resource for genetic studies. Furthermore, closely related species native to different habitats in Southeast Asia permit comparative evolutionary studies. The transparency of embryos, larvae, and juveniles allows a detailed in vivo analysis of development. New tools to study diverse aspects of medaka biology are constantly being generated. Thus, medaka has become an important vertebrate model organism to study development, behavior, and physiology. In this review, we provide a comprehensive overview of established genetic and molecular-genetic tools that render medaka fish a full-fledged vertebrate system. M EDAKA (Oryzias latipes) is a small freshwater fish of the family Adrianichthyidae in the order Beloni-formes. It is closely related to other members of the super-order Acanthopterygii of ray-finned fish such as pufferfish (tetraodon and fugu), stickleback and killifish, while it is separated from zebrafish by 150 million years (MY) of divergent evolution (Figure 1). A growing number of se-quenced teleost genomes and several established genetic model systems (zebrafish, stickleback, medaka) thus provide a unique resource for comparative studies relating to vertebrate evolution. Medaka is native to Taiwan, Korea, China, and Japan. In Japan it is found in small rivers, creeks, and rice paddies on all main islands with the exception of Hok-kaido. Medaka is a euryhaline species and can also live in brackish water (Figure 2, A and B) (Inoue and Takei 2002). As a resident of a temperate zone, medaka can tolerate a wide range of temperatures (4–40°) both as adult and embryo (Sampetrean et al. 2009). Thus, in the laboratory, temperature can be used to control the developmental speed without adverse effects. Medaka native to Japan and East Korea have a diploid karyotype of 48 chromosomes, but 46 chromosomes in medaka from West Korea and China (Uwa and Ojima 1981). The different chromosome number is due to a fusion of chromosome 11 and 13 by a Robertsonian translocation (Myosho et al. 2012b). The haploid genome size is 800 Mb (Kasahara et al. 2007). Adults can reach a length of up to 4 cm and the wild-type pigmentation is greyish-brown (Figure 2D). However, mutant strains are available where body pigmentation is strongly reduced both at embryonic and adult stages (Figure 2C) (Wakamatsu et al. 2001; Kelsh et al. 2004). Interestingly, sex-specific pigmentation can be used to distinguish male from female embryos as early as 3 days postfertilization (dpf) (organogenesis stages) (Wada et al. 1998), since the leucophore free (lf, slc2a15b) locus that is required for pigmentation by leucophores is located on the sex chromosomes X and Y (Kimura et al. 2014). The XX–XY sex determination system (see below) allows the establishment of mutant strains with females (XX) that are homozy-gous for a loss-of-function lf allele and males (XY) that are heterozygous and will therefore exhibit wild-type leucophore pigmentation. The strains, Qurt and FLF2, have the wild allele
    Genetics 04/2015; 199(4):905-918. DOI:10.1534/genetics.114.173849 · 4.87 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The animal and bacterial kingdoms have coevolved and coadapted in response to environmental selective pressures over hundreds of millions of years. The meta'omics revolution in both sequencing and its analytic pipelines is fostering an explosion of interest in how the gut microbiome impacts physiology and propensity to disease. Gut microbiome studies are inherently interdisciplinary, drawing on approaches and technical skill sets from the biomedical sciences, ecology, and computational biology. Central to unraveling the complex biology of environment, genetics, and microbiome interaction in human health and disease is a deeper understanding of the symbiosis between animals and bacteria. Experimental model systems, including mice, fish, insects, and the Hawaiian bobtail squid, continue to provide critical insight into how host-microbiota homeostasis is constructed and maintained. Here we consider how model systems are influencing current understanding of host-microbiota interactions and explore recent human microbiome studies.
    Genes & development 04/2013; 27(7):701-718. DOI:10.1101/gad.212522.112 · 12.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Deletion or duplication of one copy of the human 16p11.2 interval is tightly associated with impaired brain function, including autism spectrum disorders (ASDs), intellectual disability disorder (IDD) and other phenotypes, indicating the importance of gene dosage in this copy number variant region (CNV). The core of this CNV includes 25 genes; however, the number of genes that contribute to these phenotypes is not known. Furthermore, genes whose functional levels change with deletion or duplication (termed 'dosage sensors'), which can associate the CNV with pathologies, have not been identified in this region. Using the zebrafish as a tool, a set of 16p11.2 homologs was identified, primarily on chromosomes 3 and 12. Use of 11 phenotypic assays, spanning the first 5 days of development, demonstrated that this set of genes is highly active, such that 21 out of the 22 homologs tested showed loss-of-function phenotypes. Most genes in this region were required for nervous system development - impacting brain morphology, eye development, axonal density or organization, and motor response. In general, human genes were able to substitute for the fish homolog, demonstrating orthology and suggesting conserved molecular pathways. In a screen for 16p11.2 genes whose function is sensitive to hemizygosity, the aldolase a (aldoaa) and kinesin family member 22 (kif22) genes were identified as giving clear phenotypes when RNA levels were reduced by ~50%, suggesting that these genes are deletion dosage sensors. This study leads to two major findings. The first is that the 16p11.2 region comprises a highly active set of genes, which could present a large genetic target and might explain why multiple brain function, and other, phenotypes are associated with this interval. The second major finding is that there are (at least) two genes with deletion dosage sensor properties among the 16p11.2 set, and these could link this CNV to brain disorders such as ASD and IDD.
    Disease Models and Mechanisms 05/2012; DOI:10.1242/dmm.009944 · 5.54 Impact Factor